Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 32INDUSTRY 3NIH 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Lymphoid 317Other hematologic neoplasm 222Plasma cell 195Gynecologic 70Head & Neck 53Thoracic 51CNS 46Gastrointestinal 42Genitourinary 36Breast 36Sarcoma 35Myeloid 35Dermatologic 29Other solid neoplasm 6Endocrine 3Classical hematology 3Other 1

Conditions

Anemia 116Neoplasms 77Anemia, Refractory, with Excess of Blasts 32Myelodysplastic Syndromes 31Leukemia, Myeloid, Acute 28Venous Thromboembolism 25Thrombocytopenia 24Leukemia 22Breast Neoplasms 22Febrile Neutropenia 21Neutropenia 18Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Multiple Myeloma 15Lymphoma 14Hematologic Neoplasms 14Anemia, Sickle Cell 14Ovarian Neoplasms 12Myeloproliferative Disorders 10Leukemia, Lymphocytic, Chronic, B-Cell 10Fanconi Anemia, Complementation Group D1 10Venous Thrombosis 9Primary Myelofibrosis 9Lung Neoplasms 9Leukemia, Myelomonocytic, Chronic 9Prostatic Neoplasms 8Lymphoma, Non-Hodgkin 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Hodgkin Disease 8Pulmonary Embolism 7Hemophilia A 7

Interventions

darinaparsin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Recurrence × Classical hematology × Clear all
NCT07607327 2026-05-26

FORWARD

CareDx

Not yet recruiting
400 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Recurrence, Leukemia, Myeloid, Acute

NCT03886831 2023-03-28

A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies

Prelude Therapeutics

Phase 1 Completed
232 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Carcinoma, Adenoid Cystic, Recurrence, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Primary Myelofibrosis

NCT00592046 2012-07-19

A Phase I Trial of ZIO-101 in Hematologic Cancers

Alaunos Therapeutics

Phase 1 Completed
12 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoma, Multiple Myeloma, Myeloproliferative Disorders, Recurrence, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡